Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long-term correction of murine glycogen storage disease type Ia by recombinant adeno-associated virus-1-mediated gene transfer

29 Sept 2005

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetics and Neurodevelopmental Disorders
Share to Glycogen Storage Diseases and Myoclonus
Share to Lysosomal Storage Disorders Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 16195703
DOI: 10.1038/sj.gt.3302650

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long-term correction of murine glycogen storage disease type Ia by recombinant adeno-associated virus-1-mediated gene transferPMID 16195703Read ↗

Gene therapy for glycogen storage diseasesSemantic proximity Read ↗

Adenovirus-mediated gene therapy in a mouse model of glycogen storage disease type 1a.Semantic proximity Read ↗

Gene therapy for glycogen storage diseasesSemantic proximity Read ↗

Long‐term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type IaSemantic proximity Read ↗

Molecular biology and gene therapy for glycogen storage disease type Ib.Semantic proximity Read ↗

Rescue of GSDIII Phenotype with Gene Transfer Requires Liver- and Muscle-Targeted GDE Expression.Semantic proximity Read ↗

Gene therapy and genome editing for type I glycogen storage diseasesSemantic proximity Read ↗

Improved efficacy of gene therapy approaches for Pompe disease using a new, immune-deficient GSD-II mouse model.Semantic proximity Read ↗

Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-α-glucosidaseSemantic proximity Read ↗

Long-term correction of globotriaosylceramide storage in Fabry mice by recombinant adeno-associated virus-mediated gene transferSemantic proximity Read ↗

CRISPR/Cas9 ‐based double‐strand oligonucleotide insertion strategy corrects metabolic abnormalities in murine glycogen storage disease type‐IaSemantic proximity Read ↗

Rescue of lysosomal acid lipase deficiency in mice by rAAV8 liver gene transferSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.